Related Experiment Video
Updated: Jun 12, 2026
09:48
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
Albumin Nanoparticles for Targeted Cancer Therapy: Mechanistic Insights Into Bio-Inspired Design and Clinical
L F A Anand Raj1, Krithika Velmurugan1, Sangeetha Baskaran1
1Department of Biotechnology, St. Joseph's College of Engineering, Anna University, Chennai, Tamil Nadu, India.
Biotechnology and Bioengineering
|June 11, 2026
Summary
Albumin-based nanoparticles offer a novel approach to cancer treatment, improving drug delivery and reducing side effects. This nanotechnology enhances therapeutic outcomes for patient-centered cancer care.
Area of Science:
- Biotechnology
- Nanotechnology
- Oncology
Background:
- Conventional cancer treatments face limitations in efficacy and safety.
- Albumin-facilitated nanoscale delivery vehicles present a versatile solution to pharmacological challenges.
Purpose of the Study:
- To review the latest advances in albumin-based nanomedicine for cancer therapy.
- To discuss the potential and challenges of translating these platforms into clinical practice.
Main Methods:
- Exploration of albumin's self-assembly properties for nanostructure formation.
- Incorporation of stimuli-responsive coatings and surface ligands for targeted drug delivery.
- Review of scalable fabrication protocols and real-time monitoring techniques.
Main Results:
- Albumin nanostructures demonstrate robust drug encapsulation and selective tumor targeting.
- Stimuli-responsive designs enable synchronized drug release, reducing systemic toxicity.
- Advancements in fabrication and immunogenicity mitigation are presented.
Conclusions:
- Albumin-mediated platforms hold transformative potential for next-generation cancer care.
- Addressing clinical trial design and bioethical considerations is crucial for translation.
- Integration of patient genetic profiling can optimize treatment selection.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.